deltatrials
Completed PHASE3 NCT00048516

Safety and Efficacy of Zemplar Capsule in Reducing Serum iPTH Levels in Chronic Kidney Disease Subjects (Daily Dosing)

Sponsor: Abbott

Conditions Renal Insufficiency, Chronic
Interventions paricalcitol capsule
Updated 5 times since 2017 Last updated: Jul 31, 2006 Started: Feb 28, 2002

This PHASE3 trial investigates Renal Insufficiency, Chronic and is currently completed. Abbott leads this study, which shows 5 recorded versions since 2002 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.

Change History

5 versions recorded

  1. Sep 2024 — Present [monthly]

    Completed PHASE3

  2. Jul 2024 — Sep 2024 [monthly]

    Completed PHASE3

  3. Jan 2021 — Jul 2024 [monthly]

    Completed PHASE3

  4. Jun 2018 — Jan 2021 [monthly]

    Completed PHASE3

  5. Jan 2017 — Jun 2018 [monthly]

    Completed PHASE3

    First recorded

Feb 2002

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • Abbott
Data source: Abbott

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

Arden Hills, United States, Bialymstoku, Poland, Brooklyn, United States, Buffalo, United States, Charleston, United States, Denver, United States, Des Moines, United States, Krakow, Poland, Los Angeles, United States, Nashville, United States and 7 more location s